Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed versus non-fixed interval actinomycin-D in low-risk gestational trophoblastic neoplasia after methotrexate non-response
IRCT201706199014N170Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jun 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of actinomycin D in trophoblastic tumour (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Change in beta-hCG level. Started Jun 2017; status: completed.
02
Drugs
actinomycin D
03
Conditions
trophoblastic tumour
Beyond the preview
Go deeper on IRCT201706199014N170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201706199014N170.